Biblio
Journal Article
Zhang X, Jia D, Ao J, Liu H, Zang Y, Azam M, Habib S, Li J, Ruan X, Jia H, et al. Identification of Bisindolylmaleimide IX as a potential agent to treat drug-resistant BCR-ABL positive leukemia. Oncotarget. 2016.
Fan C, Wunderlich M, Cai X, Yan Z, Zhang F, Davis AKuenzi, Xu L, Guo F, Q Lu R, Azam M, et al. Kinase-independent role of mTOR and on-/off-target effects of an mTOR kinase inhibitor. Leukemia. 2023.